Abstract:Abstract Background Despite the latest progress in heart failure therapy, early diagnosis and clinical prognosis prediction are still critical issues nowadays. It has been proved that carnitines play an essential role in fatty acid metabolism. However, it is unclear about the changes and clinical effects of circulating carnitines in heart failure. Objectives This study was designed to clarify the alteration of serum carnitine and its derivates in heart failure patients, and to verify the impact of carnitines on heart failure etiology discrimination and mortality prediction. Methods A total of 161 heart failure patients (Dilated cardiomyopathy: DCM, n=98; ischemia cardiomyopathy: ICM, n=63) and control patients (n=48) were enrolled from Feb to Sep in 2017. Serum L-carnitines were quantitatively measured by liquid chromatography/ mass spectrometry. All patients underwent follow-up (mean 30.8 months). Multi-variable Cox survival was performed to verify the impact of carnitines on heart failure mortality prediction. Results A total of 27 different carnitine derivates were detected. Compared with control group, 26 types of carnitines were increased significantly in heart failure patients. Several circulating carnitines were independent biomarkers for heart failure even adjusted by multi-variable logistic analysis. We also found 7 carnitines were obviously increased in DCM group than those in ICM group. Isobutyryl-L-carnitine and stearoyl-L-carnitine were independently associated with higher probability of DCM than ICM. DCM prediction model established by adding carnitines (isobutyryl-L-carnitine and stearoyl-L-carnitine) to age, serum creatinine and left ventricular ejection fraction,had favorable discrimination (C-index = 0.832, P<0.01, Figure 1A and B) and calibration efficiency (Hosmer-Lemeshow χ2=7.376, P=0.497>0.05). Meanwhile, a total of 43 mortality event occurred, 18 death (31.6%) in ICM group and 25 (27.2%) in DCM group. Independent clinical risk factors for the occurrence of mortality were serum creatinine >2mg/dl, left atrial diameter 0.55mm and N-terminal pro-B-type natriuretic peptide >4000 pg/ml. Using multi-variable COX survival analysis simultaneously adjusted by serum creatinine, left atrial diameter, NT-pro-BNP and age, oleoyl L-carnitine >300nmo/L (HR=2.364, 95% CI: 1.122–4.976, P=0.024) and isovaleryl-L-carnitine <100nmol/L (HR=2.108, 95% CI: 1.091–4.074, P=0.026) were also independently associated with higher mortality. Conclusions As one of critical participants in fatty acid metabolism, L-carnitines alteration not only differentiates DCM patients from ICM ones, but also independently predicts the risk of long-term mortality in heart failure patients. Figure 1 Funding Acknowledgement Type of funding source: Public grant(s) – National budget only. Main funding source(s): National Natural Science Foundation of China, Grant of Shanghai Municipal Commission of Health and Family Planning

[Significance of Serum Carnitine in Patients with Liver Diseases].

Clinical Signiifcance of Liver Function in Connective Tissue Disease-related Pulmonary Arterial Hypertension

Plasma Total Carnitine and Free Carnitine Level in Healthy Adults and Patients with Liver Diseases

Clinical Significance of the Serum Neopterin Detection in Patients with Liver Cirrhosis

High L-Carnitine Levels Impede Viral Control in Chronic Hepatitis B Virus Infection

Automated Enzymatic Determination for Serum Total and Free L-carnitine and Its Clinical Application

The Clinical Significance of the Change of Blood-Lipid in Patients with Hepatitis B-related Cirrhosis.

Usefulness of Carnitine Supplementation for the Complications of Liver Cirrhosis

To Investigate Plasma Levels of Free and Total Carnitine in Patients Undergoing Hemodialysis or Peritoneal Dialysis

The Level and Significance of Serum IL-6,TNF-α and L-carnitine in Hemodialysis Patients

Level of plasma L-carnitine in patients with coronary heart disease

Quantitative Profiling of Serum Carnitines Facilitates the Etiology Diagnosis and Prognosis Prediction in Heart Failure

Role of carnitine in disease

Effect of l -carnitine therapy on patients in maintenance hemodialysis: a systematic review and meta-analysis

The Importance of the Fatty Acid Transporter L-Carnitine in Non-Alcoholic Fatty Liver Disease (NAFLD)

Quantitative Determination of Circulating L-cartinine and Its Derivates Contributes to Heart Failure Diagnosis, Etiology Discrimination and Clinical Prognosis Prediction

Serum Metabolomics Reveals the Deregulation of Fatty Acids Metabolism in Hepatocellular Carcinoma and Chronic Liver Diseases

Significance of Levels of Serum Prealbumin,r-Glutamyl Transferase,total Acid,cholesterol and Blood Coagulation Function for the Grading of Liver Function and Prognosis of Cirrhosis

l-carnitine: Nutrition, pathology, and health benefits

[Assay of Carnitine in Plasma and Urine of Healthy Adults].

Lower carnitine plasma values from malnutrition cancer patients